Sign in
4

Changes in Ownership

Actinium Pharmaceuticals, Inc. Filed Acc 0001213900-18-009320

Options or other derivatives

  • Chief Medical Officer acquired 250,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Berger Mark Stanley · Chief Medical Officer

Table II: Derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2018-07-13 Grant or award : show line 1 in the form Options to purchase common stock +250,000 $0.78 $195,725 250,000 D
Loading xslF345X03/ownership.xml…